India · Delayed Price · Currency is INR Epigral Statistics
Total Valuation
Epigral has a market cap or net worth of INR 47.75 billion. The enterprise value is 53.42 billion.
| Market Cap | 47.75B |
| Enterprise Value | 53.42B |
Important Dates
The last earnings date was Monday, July 27, 2026.
| Earnings Date | Jul 27, 2026 |
| Ex-Dividend Date | Jun 1, 2026 |
Share Statistics
Epigral has 43.14 million shares outstanding. The number of shares has increased by 1.18% in one year.
| Current Share Class | 43.14M |
| Shares Outstanding | 43.14M |
| Shares Change (YoY) | +1.18% |
| Shares Change (QoQ) | -0.02% |
| Owned by Insiders (%) | 69.01% |
| Owned by Institutions (%) | 4.68% |
| Float | 11.98M |
Valuation Ratios
The trailing PE ratio is 17.62 and the forward PE ratio is 13.78.
| PE Ratio | 17.62 |
| Forward PE | 13.78 |
| PS Ratio | 1.82 |
| PB Ratio | 2.15 |
| P/TBV Ratio | 2.16 |
| P/FCF Ratio | 115.40 |
| P/OCF Ratio | 10.96 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 9.06, with an EV/FCF ratio of 129.10.
| EV / Earnings | 19.71 |
| EV / Sales | 2.03 |
| EV / EBITDA | 9.06 |
| EV / EBIT | 12.92 |
| EV / FCF | 129.10 |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.26 |
| Debt / EBITDA | 0.97 |
| Debt / FCF | 13.82 |
| Interest Coverage | 13.58 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 10.96% |
| Return on Capital Employed (ROCE) | n/a |
| Weighted Average Cost of Capital (WACC) | 5.17% |
| Revenue Per Employee | 23.14M |
| Profits Per Employee | 2.39M |
| Employee Count | 1,135 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Epigral has paid 964.70 million in taxes.
| Income Tax | 964.70M |
| Effective Tax Rate | 26.25% |
Stock Price Statistics
The stock price has decreased by -39.30% in the last 52 weeks. The beta is 0.20, so Epigral's price volatility has been lower than the market average.
| Beta (5Y) | 0.20 |
| 52-Week Price Change | -39.30% |
| 50-Day Moving Average | 1,100.87 |
| 200-Day Moving Average | 1,184.33 |
| Relative Strength Index (RSI) | 49.96 |
| Average Volume (20 Days) | 122,883 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Epigral had revenue of INR 26.26 billion and earned 2.71 billion in profits. Earnings per share was 62.82.
| Revenue | 26.26B |
| Gross Profit | 9.78B |
| Operating Income | 4.14B |
| Pretax Income | 3.67B |
| Net Income | 2.71B |
| EBITDA | 5.82B |
| EBIT | 4.14B |
| Earnings Per Share (EPS) | 62.82 |
Balance Sheet
The company has 50.20 million in cash and 5.72 billion in debt, with a net cash position of -5.67 billion or -131.43 per share.
| Cash & Cash Equivalents | 50.20M |
| Total Debt | 5.72B |
| Net Cash | -5.67B |
| Net Cash Per Share | -131.43 |
| Equity (Book Value) | 22.21B |
| Book Value Per Share | 514.92 |
| Working Capital | n/a |
Cash Flow
In the last 12 months, operating cash flow was 4.36 billion and capital expenditures -3.94 billion, giving a free cash flow of 413.80 million.
| Operating Cash Flow | 4.36B |
| Capital Expenditures | -3.94B |
| Depreciation & Amortization | 1.68B |
| Net Borrowing | -274.70M |
| Free Cash Flow | 413.80M |
| FCF Per Share | 9.59 |
Margins
Gross margin is 37.24%, with operating and profit margins of 15.78% and 10.32%.
| Gross Margin | 37.24% |
| Operating Margin | 15.78% |
| Pretax Margin | 13.99% |
| Profit Margin | 10.32% |
| EBITDA Margin | 22.17% |
| EBIT Margin | 15.78% |
| FCF Margin | 1.64% |
Dividends & Yields
This stock pays an annual dividend of 5.00, which amounts to a dividend yield of 0.44%.
| Dividend Per Share | 5.00 |
| Dividend Yield | 0.44% |
| Dividend Growth (YoY) | -16.67% |
| Years of Dividend Growth | 1 |
| Payout Ratio | n/a |
| Buyback Yield | -1.18% |
| Shareholder Yield | -0.73% |
| Earnings Yield | 5.68% |
| FCF Yield | 0.87% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for Epigral is 1,728.00, which is 55.40% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | 1,728.00 |
| Price Target Difference | 55.40% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 3 |